InterVenn Stock
HealthTechLooking to sell InterVenn stock or options?
InterVenn is the creator of a biomarker and target discovery platform that is designed to assist in the identification and prioritization of ovarian and other cancers. The platform developed by InterVenn concentrates on locating, quantifying, and categorizing glycoproteomic and PTM signals present in human blood and tissue for the purpose of target discovery and validation. This allows healthcare professionals to diagnose cancer at an early stage, thereby enhancing patient care.
Amplify Partners, Irving Investors, Oriza Ventures, Heritage Provider Network, Anzu Partners, AG Hill Partners, True Ventures, Highside Capital Management, SoftBank Investment Advisers, Genoa Ventures, Tatiana Ojjeh, Boost VC, Xeraya Capital.